- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kyntra Bio Inc (KYNB)
Track today's live Kyntra Bio (KYNB) share price, performance and key data on this page with our current NASDAQ:KYNB stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Kyntra Bio share price on the NASDAQ exchange. Use the dropdown to switch exchange for the KYNB share price, head to our technical summary section, which provides analysis on Kyntra Bio share price buy/sell indicators using real-time data (or discuss the Kyntra Bio (KYNB) stock price today with other investors in the Kyntra Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:KYNB share price (ISIN: US31572Q8814) to enhance your trading decisions with our free investment tools and resources.
What Is the Kyntra Bio Inc Share Price Today?
The Kyntra Bio share price today is 7.451.
What Is the Stock Symbol for Kyntra Bio Inc
The stock symbol (or 'ticker') for Kyntra Bio Inc is "KYNB."
What Stock Exchange Does Kyntra Bio Inc Trade On?
Kyntra Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Kyntra Bio Inc a Good Stock to Buy?
Determining whether Kyntra Bio (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:KYNB share price (ISIN: US31572Q8814) to enhance your trading decisions with our free investment tools and resources.
What Is the Kyntra Bio Inc Share Price Today?
The Kyntra Bio share price today is 7.451.
What Is the Stock Symbol for Kyntra Bio Inc
The stock symbol (or 'ticker') for Kyntra Bio Inc is "KYNB."
What Stock Exchange Does Kyntra Bio Inc Trade On?
Kyntra Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Kyntra Bio Inc a Good Stock to Buy?
Determining whether Kyntra Bio (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Currency in USD
7.451
-0.090(-1.19%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.451
7.600
52 wk Range
5.620
12.600
KYNB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.4517.600
52 wk Range
5.62012.600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KYNB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
39.000
Upside
+423.42%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Kyntra Bio stock rises on roxadustat MDS trial data
- Investing.com
- Form 4 Kyntra Bio Inc For: 17 June
- Investing.com
- Form 4 Kyntra Bio Inc For: 17 June
- Investing.com
- Form 8K Kyntra Bio Inc For: 16 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 39.000
(+423.42% Upside)
Kyntra Bio Inc Earnings Call Summary for Q2/2025
- FibroGen reports Q2 2025 EPS of -$1.88, missing forecast of -$0.09; revenue falls short at $1.3M vs $2.88M expected
- Stock drops 3.9% to $8.71 post-earnings; company valued at $34M market cap, deemed overvalued by InvestingPro analysis
- Operating costs decrease 72% YoY; R&D expenses down 82%; company extends cash runway to 2028
- Full-year 2025 revenue guidance set at $6M-$8M; Phase II trial for prostate cancer treatment FG3246 to begin Q3 2025
- CEO expresses optimism about clinical programs; CFO highlights financial strategies to benefit shareholders
Last Updated: 11/08/2025, 22:46
Read Full TranscriptEarnings
Latest Release
11/05/2026
EPS / Forecast
-3.76 / -0.21
Revenue / Forecast
3.7M / 1.51M
Compare KYNB to Peers and Sector
Metrics to compare | KYNB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKYNBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | 12.9x | −0.4x | |
PEG Ratio | 0.00 | 0.04 | 0.00 | |
Price/Book | −0.7x | 3.1x | 2.6x | |
Price / LTM Sales | 4.1x | 4.2x | 3.0x | |
Upside (Analyst Target) | - | 91.3% | 49.7% | |
Fair Value Upside | Unlock | 12.5% | 7.3% | Unlock |
Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers. It is also developing Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was formerly known as FibroGen, Inc. and change its name to Kyntra Bio, Inc. in January 2026. Kyntra Bio, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Kyntra Bio (NASDAQ: KYNB) Share Price Today?
The Kyntra Bio stock price today is 7.451 USD.
What Stock Exchange Does Kyntra Bio (KYNB) Trade On?
Kyntra Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Kyntra Bio?
The stock symbol (also called a 'ticker') for Kyntra Bio is "KYNB."
What Is the Current Kyntra Bio Market Capitalisation?
As of today, Kyntra Bio (NASDAQ: KYNB) market cap is 30.160M USD.
What Is Kyntra Bio's (KYNB) Earnings Per Share (TTM)?
The Kyntra Bio EPS is currently -13.984 (Trailing Twelve Months).
When Is the Next Kyntra Bio Earnings Date?
Kyntra Bio's next earnings report will be released on 10/08/2026.
Is KYNB a Buy or Sell From a Technical Analyst Perspective?
Based on today's Kyntra Bio moving averages and other technical indicators, the daily buy/sell signal for KYNB stock is Strong Buy.
How Many Times Has Kyntra Bio Stock Split?
Kyntra Bio has split 1 times. (See the KYNB stock split history page for full effective split date and price information.)
How Many Employees Does Kyntra Bio Have?
Kyntra Bio has 34 employees, based on their latest Companies House report.
What is the current trading status of Kyntra Bio (NASDAQ: KYNB)?
As of 08/07/2026, Kyntra Bio (KYNB) is trading at a share price of 7.451 USD, with a previous close of 7.540 USD. The stock has fluctuated within a day range of 7.451 USD to 7.600 USD, while its 52-week range spans from 5.620 USD to 12.600 USD.
What Is Kyntra Bio (KYNB) Price Target According to Analysts?
The average 12-month price target for Kyntra Bio is 39.000 USD, with a high estimate of 43 USD and a low estimate of 35 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +423.42% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.